Home> Products> miltefosine treatment for cutaneous leishmaniasis

{ "products": [ { "_id": "6a952bdada41ea9aeeec5e4a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide injection 8 mg", "description": "The semaglutide injection, 8 mg, contains a total of 8 mg of semaglutide, a long-acting GLP-1 receptor agonist. It is used under medical supervision as part of treatment for appropriate adults with type 2 diabetes mellitus and, depending on the specific approved product and indication, for cardiovascular risk reduction and chronic weight management.\n1. Product Overview & Specifications\nAn 8 mg/3 mL semaglutide pen contains 8 mg of the active medicine in a 3 mL delivery system. When specifically designed to provide 2 mg per weekly dose, the total quantity can provide four 2 mg doses.\nActive Ingredient: Semaglutide\nTotal Strength: 8 mg\nExample Presentation: 8 mg/3 mL multi-dose pen\nDrug Class: GLP-1 receptor agonist\nRoute: Subcutaneous injection\nCommon Injection Areas: Abdomen, thigh, or upper arm\nAdministration: Once weekly, according to the prescribed schedule\nMechanism of Action\nSemaglutide mimics the activity of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). It acts on GLP-1 receptors involved in blood-glucose regulation, digestion, and appetite.\nImproves glucose-dependent insulin release: Semaglutide encourages the pancreas to release insulin when blood glucose levels are elevated.\nReduces glucagon secretion: It lowers inappropriate glucagon release, helping reduce the amount of glucose produced by the liver.\nSlows gastric emptying: Semaglutide can delay the movement of food from the stomach, contributing to prolonged fullness.\nReduces appetite: Its effects on appetite-regulating pathways in the brain can decrease hunger and food intake.\n2. Primary Indications & Uses\nSemaglutide may be prescribed for several clinically established purposes depending on the specific formulation, approved labeling, and patient's medical condition.\nType 2 Diabetes Management\nSemaglutide can be used alongside appropriate diet and physical activity to improve blood-glucose control in adults with type 2 diabetes.\nCardiovascular Risk Reduction\nIn eligible adults with type 2 diabetes and established cardiovascular disease, certain semaglutide products have demonstrated a reduction in the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke.\nKidney Disease\nCertain semaglutide formulations and indications have demonstrated kidney-related benefits in specific populations. The appropriate product and indication should be determined by a healthcare professional.\nChronic Weight Management\nSemaglutide is also used for long-term weight management in eligible adults with obesity or overweight accompanied by weight-related health conditions, depending on the approved formulation and local prescribing guidance.\n3. Key Benefits of Semaglutide 8 mg Therapy\nClinical Area\nPotential Therapeutic Role\nBlood-Glucose Control\nHelps lower elevated blood glucose and improve glycemic control in appropriate patients.\nWeight Management\nReduces appetite and food intake, supporting sustained weight reduction when prescribed for this purpose.\nCardiovascular Health\nCertain approved semaglutide indications can reduce major cardiovascular event risk in eligible patients.\nMetabolic Support\nInfluences glucose regulation, appetite, insulin secretion, and glucagon activity.\nWeekly Administration\nA once-weekly injection can provide a convenient treatment schedule when prescribed.\n\n4. Side Effects & Safety Warnings\nCommon Adverse Reactions\nDigestive symptoms are among the most frequently reported adverse effects, particularly when treatment is initiated or the dose is increased.\nPossible side effects include:\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nBloating\nBelching\nIndigestion or heartburn\nReduced appetite\nThese effects may improve as the body becomes accustomed to treatment.\nFrequently Asked Questions\n1. How much weight can you lose with semaglutide?\nWeight reduction varies significantly between individuals and depends on the prescribed formulation, dose, treatment duration, diet, physical activity, and adherence. Clinical trials of approved weight-management regimens have demonstrated substantial average percentage weight loss over extended treatment periods.\n2. How much is 8 units of semaglutide in mL?\nOn a U-100 insulin syringe, 100 units corresponds to 1 mL, so 8 units corresponds to 0.08 mL. However, this conversion only describes syringe volume. It does not determine the amount of semaglutide in mg because the medication concentration varies between products. Always verify the exact concentration before measuring any dose.\n3. Is semaglutide injection safe for weight loss?\nSemaglutide can be an effective treatment for weight management when an approved formulation is prescribed to an eligible patient and used under appropriate medical supervision. It has important contraindications and warnings, including risks involving the gastrointestinal system, gallbladder, pancreas, kidneys, and thyroid C-cell tumors.\n4. How many mg of semaglutide are used for weight loss?\nThe appropriate dose depends on the specific semaglutide product. Weight-management treatment commonly begins with a lower dose and is gradually increased to a maintenance dose to improve tolerability. The maintenance dose should be determined according to the product's approved prescribing information and the healthcare professional's instructions.\n5. How much weight can I lose in 2 months with semaglutide?\nThere is no guaranteed amount of weight loss during the first two months. Individual results vary because treatment generally begins at a lower dose and is increased gradually. Diet, physical activity, starting weight, medical conditions, and adherence also affect the result.\n6. What happens when you stop semaglutide?\nAfter discontinuation, semaglutide gradually leaves the body. Appetite and food intake may increase as its effects decrease, and some people regain weight. Maintaining healthy eating and physical activity habits may help support weight management after treatment, but discontinuation should be discussed with a healthcare professional.\n7. How long does an 8 mg/3 mL semaglutide pen last?\nIf a specific 8 mg/3 mL pen is designed to deliver 2 mg per weekly dose, it contains four 2 mg doses and therefore provides approximately four weeks of treatment. The actual duration depends on the specific device and prescribed dosing instructions.\n8. What is semaglutide injection 8 mg used for?\nSemaglutide is used for approved indications such as improving blood-glucose control in type 2 diabetes and, depending on the formulation, supporting chronic weight management and reducing cardiovascular risk in eligible patients.\n9. What foods should be avoided while taking semaglutide?\nLarge, high-fat, greasy, or fried meals may worsen gastrointestinal symptoms such as nausea, bloating, and reflux. Smaller meals and balanced food choices may be easier to tolerate. Alcohol intake should also be discussed with a healthcare professional.\n10. Can you eat bananas while taking semaglutide?\nYes, bananas can generally be included in a balanced diet while using semaglutide. Portion size should be considered as part of an individual's overall calorie and carbohydrate intake, particularly for people managing diabetes.\n11. What is the best time of day to inject semaglutide?\nSemaglutide injections can generally be administered at any time of day, with or without meals, depending on the specific product instructions. The injection should be taken on the same day each week as prescribed.\n12. Will I lose weight during the first week of semaglutide?\nSome people may notice an early change in appetite or body weight, while others may not see a significant difference initially. Early treatment doses are generally introduced gradually to help the body adjust rather than to produce immediate maximum weight loss.\n13. How quickly does semaglutide start lowering blood sugar?\nSemaglutide begins acting after administration, but the degree and timing of blood-glucose improvement vary. Significant treatment effects develop progressively, particularly as the prescribed dose is gradually adjusted.\n14. What should I do if I miss a semaglutide dose?\nThe correct missed-dose procedure depends on the specific semaglutide product. Follow the instructions supplied with your prescribed product. Do not take an extra dose to compensate for a missed injection.\n15. Where is the best place to inject semaglutide?\nSemaglutide is administered subcutaneously. Common injection sites include the abdomen, front of the thigh, or upper arm, according to the product instructions. Rotating injection locations can help reduce repeated irritation at one site.\nConclusion\nSemaglutide injection 8 mg contains semaglutide, a long-acting GLP-1 receptor agonist that influences blood-glucose regulation, glucagon secretion, gastric emptying, and appetite. Depending on the specific formulation and approved indication, semaglutide may be used for type 2 diabetes management, chronic weight management, and cardiovascular risk reduction in eligible patients.\nAn 8 mg/3 mL presentation designed for 2 mg weekly dosing can provide four weekly doses. However, semaglutide concentrations, pen designs, approved doses, and indications can differ between products. Treatment should therefore follow the exact product instructions and a healthcare professional's prescription.", "price": 7800.0, "discountamount": 2340.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2498, "imageuri": "https://productimages.withfloats.com/actual/6a952bdd8359c1b7edbc7468.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a952bdd8359c1b7edbc7468.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T07:23:06.814Z", "updatedon": "2026-08-31T07:23:06.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/semaglutide-injection-8-mg/2498", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 8MG", "category": "DIABETIC RANGE", "tags": [ "Semaglutide injection 8 mg", "semaglutide injection 8 mg", "semaglutide 8 mg injection uses", "semaglutide 8 mg injection benefits", "semaglutide 8 mg injection dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c3838c90065ecdc86c757", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 4mg", "description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.", "price": 6600.0, "discountamount": 1980.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2497, "imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:25:28.659Z", "updatedon": "2026-08-24T12:25:28.659Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-4mg/2497", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 4 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c35e76d1f6b0cbc0e2e40", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 2 mg", "description": "SAMIGLUTIDE 2 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation is Semaglutide Injection 2 mg/3 mL (0.68 mg/mL). Semaglutide belongs to the GLP-1 receptor agonist class and is a prescription medicine that should be used only under the supervision of an appropriately qualified healthcare professional.\n\nSAMIGLUTIDE 2 MG Composition\n\nEach 3 mL pre-filled pen is stated to contain:\n\nActive substance: Semaglutide\nStrength: 2 mg/3 mL\nConcentration: 0.68 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute of administration: Subcutaneous, according to the applicable product instructions\n\nSemaglutide acts on GLP-1 receptors, which are involved in blood-glucose regulation and appetite control. The approved uses, dosage regimen and strength available can differ according to the specific product and the regulations of the country in which it is supplied.\n\nWhat Is Semaglutide?\n\nSemaglutide is a synthetic peptide that mimics the activity of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). By activating GLP-1 receptors, it can influence several physiological processes, including glucose-dependent insulin release, glucagon secretion, gastric emptying and appetite.\n\nThe appropriate dose and treatment schedule depend on the individual patient and the particular semaglutide formulation. Patients should follow their healthcare professional's instructions and should not alter the prescribed regimen independently.\n\nSAMIGLUTIDE 2 MG Pre-Filled Pen\n\nSAMIGLUTIDE 2 MG is presented as a pre-filled injection pen intended to provide a convenient method of administration when the medicine has been prescribed.\n\nSince semaglutide products can differ in concentration, pen design and dose-delivery mechanism, users should carefully verify the product label and prescribed dose before each administration. Particular care is important with injectable semaglutide products because differences in concentration or measurement methods can result in medication errors.\n\nPotential Medical Uses\n\nSemaglutide may be used for particular medical conditions depending on the formulation, regulatory approval and prescribing information applicable to the product.\n\nCertain approved semaglutide medicines are indicated for the treatment of type 2 diabetes, while other formulations have approved indications involving chronic weight management in eligible patients. Some products may also have additional approved indications for reducing specific cardiovascular risks.\n\nThe fact that semaglutide can be used for weight management does not mean that every semaglutide product is approved for that purpose. The authorization and labeling of SAMIGLUTIDE should therefore be confirmed from current official product documentation.\n\nHow Semaglutide Works\n\nSemaglutide activates GLP-1 receptors in the body. Its effects can contribute to improved regulation of blood glucose and reduced appetite and food intake. Depending on the approved indication, it may be prescribed together with dietary, physical-activity or other appropriate medical measures.\n\nIndividual responses can vary. Medical follow-up helps healthcare professionals evaluate treatment response, tolerability and whether treatment should be continued or modified.\n\nDosage and Administration\n\nSAMIGLUTIDE 2 MG should be administered only in accordance with the prescription and the manufacturer's current instructions.\n\nThe amount of semaglutide contained in a pen should not automatically be interpreted as the amount to inject at one time. Different products may use different concentrations, dose settings and administration schedules.\n\nFor approved semaglutide products, treatment may involve gradual dose increases for certain indications. Patients should never increase the dose, inject more frequently or repeat a missed dose without receiving appropriate medical instructions.\n\nPossible Side Effects\n\nSemaglutide can cause adverse effects, particularly gastrointestinal symptoms. Frequently reported effects may include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nAbdominal pain\n\nMore serious reactions are also possible. Product information for semaglutide medicines includes warnings relating to conditions such as pancreatitis and gallbladder disorders, among other potential risks.\n\nPersistent, severe or unusual symptoms should be discussed promptly with a healthcare professional. Patients should review the complete prescribing information supplied with their particular product.\n\nImportant Safety Information\n\nSemaglutide is not appropriate for everyone. For example, certain approved semaglutide products in the United States carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and individuals with a serious hypersensitivity to semaglutide or an ingredient in the relevant product.\n\nThese precautions should not automatically be assumed to apply identically to every semaglutide product worldwide. The manufacturer's labeling and the regulatory requirements of the relevant country should always be consulted.\n\nPatients should inform their healthcare professional about their medical history and other medicines before starting treatment.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can make injectable treatment more convenient by providing the medication in a ready-to-use delivery device. When used according to the manufacturer's instructions, the pen may simplify administration and help patients maintain their prescribed treatment routine.\n\nPatients should nevertheless receive appropriate guidance regarding injection technique, storage, handling and disposal. The convenience of a pen does not eliminate the need for medical supervision.\n\nStorage and Handling\n\nSAMIGLUTIDE 2 MG should be stored exactly as stated on its packaging and official product information. Appropriate storage conditions are important for maintaining the quality and stability of the medicine.\n\nBefore use, check the expiry date and inspect the packaging and medicine according to the manufacturer's instructions. Do not use the product if the packaging is damaged or if the solution has an appearance that does not meet the stated product requirements.\n\nConclusion\n\nSAMIGLUTIDE 2 MG – Semaglutide Injection 2 mg/3 mL (0.68 mg/mL) is a semaglutide-based injectable formulation supplied in a pre-filled pen. Semaglutide is a GLP-1 receptor agonist with established medical applications for appropriately selected patients, depending on the specific product and its regulatory authorization.\n\nSafe use requires adherence to the prescribed dose and administration schedule. Patients should not independently change their dose or frequency and should seek professional advice if they experience concerning adverse effects.\n\nBecause formulations, indications, strengths and regulatory requirements can vary between products and countries, the current official package insert and applicable regulatory labeling should be used to verify product-specific information.\n\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 2 MG?\n\nSAMIGLUTIDE 2 MG is described as a semaglutide injection containing 2 mg of semaglutide in 3 mL, with a stated concentration of 0.68 mg/mL, supplied in a pre-filled pen.\n\nIs SAMIGLUTIDE 2 MG used for weight management?\n\nSemaglutide is included in certain approved medicines used for chronic weight management in eligible patients. However, the indication for a specific SAMIGLUTIDE product must be confirmed from its current regulatory approval and official labeling.\n\nHow frequently is SAMIGLUTIDE 2 MG injected?\n\nThe correct frequency depends on the specific product and the prescription issued by the healthcare professional. Patients should not determine the injection schedule based solely on the amount printed on the pen.\n\nCan SAMIGLUTIDE 2 MG be taken without medical supervision?\n\nNo. Semaglutide is a prescription medicine in many jurisdictions and should be obtained and used through legitimate, appropriately regulated healthcare channels.\n\nIs SAMIGLUTIDE the same as other branded semaglutide medicines?\n\nNot necessarily. Products containing semaglutide can differ in manufacturer, formulation, concentration, delivery device, regulatory approval and approved indications. A specific product should not be described as identical to an approved branded medicine unless that claim can be verified through reliable regulatory and product documentation.\n\nWhat should patients check before using the pen?\n\nPatients should verify the medicine name, strength, prescribed dose, expiry date, storage conditions and administration instructions. If there is any uncertainty about the dose or operation of the pen, they should consult their pharmacist, prescriber or another qualified healthcare professional rather than guessing.", "price": 5600.0, "discountamount": 1680.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2496, "imageuri": "https://productimages.withfloats.com/actual/6a8c35eaca4d2575d78e3716.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c35eaca4d2575d78e3716.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:15:35.873Z", "updatedon": "2026-08-24T12:15:35.873Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-2-mg/2496", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 2 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a7722af7f45a0190eb37920", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tolperisone Hydrochloride & Paracetamol Tablets", "description": "TOPERITIME P 150/325: Dual-Action Relief for Musculoskeletal Pain and Spasms\nTOPERITIME P 150/325 is a prescription combination therapy formulated to treat acute musculoskeletal discomfort, muscle stiffness, and associated inflammatory pain. By uniting a centrally acting muscle relaxant with a proven analgesic, this film-coated tablet addresses both the neurological and physical aspects of muscle strain, restoring movement and facilitating recovery.\n\nActive Ingredients\nEach film-coated tablet contains:\n\nTolperisone Hydrochloride (150 mg): A muscle relaxant targeting involuntary contractions within the central nervous system.\n\nParacetamol (325 mg): A widely recognized analgesic and antipyretic agent that blocks pain signal transmission.\n\nAvailable in blister packaging and dispensed strictly under a licensed physician's order.\n\nTherapeutic Mechanism\nPainful muscle conditions often create a feedback loop where localized pain triggers involuntary spasms, which in turn exacerbate the pain. TOPERITIME P 150/325 disrupts this cycle through a two-pronged mechanism:\n\nNeuromuscular Regulation: Tolperisone Hydrochloride acts on the spinal cord and brainstem reflexes to inhibit hyperactive nerve impulses driving muscle tension. Unlike traditional skeletal muscle relaxants, it achieves this with minimal central nervous system depression, significantly reducing the likelihood of heavy sedation.\n\nNociceptive Blocking: Paracetamol inhibits prostaglandin synthesis within the central nervous system, raising the body's overall pain threshold and attenuating pain signals originating from injured tissues.\n\nBy simultaneously relaxing tight muscle fibers and dampening pain sensation, the formulation provides comprehensive symptomatic relief.\n\nClinical Indications\nHealthcare professionals may prescribe TOPERITIME P 150/325 for various acute and subacute conditions characterized by pain and hypertonia, including:\n\nAcute muscle spasms and athletic injuries\n\nAcute or chronic lower back pain (lumbago)\n\nCervical spine discomfort and stiff neck\n\nCervical and lumbar spondylosis\n\nFrozen shoulder (adhesive capsulitis)\n\nPost-operative or post-traumatic muscle recovery\n\nGeneralized connective tissue or orthopedic pain\n\nKey Clinical Features\nBalanced Dual Action: Simultaneously targets involuntary contractions and pain sensation.\n\nLow-Sedation Profile: Tolperisone allows patients to maintain daily function without severe daytime drowsiness typical of older relaxants.\n\nEnhanced Mobility: Reduces joint and tissue stiffness, enabling better engagement in physical rehabilitation.\n\nStreamlined Regimen: Combines two therapeutic agents into a single convenient dosage form.\n\nUsage Guidelines\nThis medication must be taken strictly in accordance with a medical prescription.\n\nAdministration: Swallow the tablet whole with water. Do not crush, chew, or split the film-coated tablet.\n\nTiming: Take immediately after a meal to reduce potential gastrointestinal upset, unless directed otherwise by a doctor.\n\nCompliance: Complete the full course prescribed by your physician, and do not alter the recommended dosage.\n\nPotential Side Effects\nWhile generally well-tolerated, some individuals may experience mild side effects, including:\n\nGastrointestinal distress or mild nausea\n\nTransient dizziness or lightheadedness\n\nHeadaches\n\nGeneral fatigue or muscular weakness\n\nRare: Hypersensitivity reactions or cutaneous skin rashes (discontinue use and consult a physician immediately if severe symptoms appear).\n\nSafety Precautions and Considerations\nConsult a medical practitioner prior to initiating treatment if any of the following apply:\n\nPre-existing hepatic (liver) or renal (kidney) impairment\n\nKnown hypersensitivity to Tolperisone, Paracetamol, or related compounds\n\nPregnancy, plans for pregnancy, or active breastfeeding\n\nHistory of chronic alcohol dependency (due to increased liver sensitivity with Paracetamol)\n\nConcurrent use of other medications, particularly other products containing Paracetamol or central nervous system depressants\n\nStorage and Handling\nStore in a cool, dry area below 25°C (77°F).\n\nProtect from direct light, heat, and moisture.\n\nKeep strictly out of reach of children and pets.\n\nCheck the packaging expiration date before administration.\n\nFrequently Asked Questions\nWhat primary conditions does TOPERITIME P 150/325 treat?\n\nIt is indicated for short-term relief from acute musculoskeletal pain, muscle spasms, neck strains, backaches, and related orthopedic disorders.\n\nWhy is Tolperisone combined with Paracetamol?\n\nTolperisone eases muscle tightness at the neurological level, while Paracetamol lowers overall pain perception, creating a synergistic effect that addresses both spasm and pain together.\n\nWill this medication cause severe drowsiness?\n\nTolperisone is specifically designed to exert less sedating activity compared to older muscle relaxants. However, individual sensitivity varies, so caution is advised when driving or operating machinery until individual tolerance is established.\n\nIs TOPERITIME P 150/325 available over the counter?\n\nNo. It requires a valid medical prescription and direct supervision by a registered healthcare professional.", "price": 95.0, "discountamount": 29.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2493, "imageuri": "https://productimages.withfloats.com/actual/6a7722b0ed25653efa18364e.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a7722b0ed25653efa18364e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-08T12:35:59.075Z", "updatedon": "2026-08-08T12:35:59.075Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tolperisone-hydrochloride-paracetamol-tablets/2493", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TOPERITIME P 150/325", "category": "ORTHOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a5de55aa467a7e64774de83", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Teneligliptin 20mg,Pioglitazone 15mg & Metformin Hydrochloride (Sustained Release) 1000mg Tablets", "description": "TENELIGOLD PM 1000 brings together three antidiabetic agents — Teneligliptin 20 mg, Pioglitazone 15 mg, and Metformin Hydrochloride (Sustained Release) 1000 mg — in a single tablet built to support glycemic control in adults living with Type 2 Diabetes Mellitus (T2DM). Rather than relying on one pathway, this triple-action formula addresses blood glucose from several angles at once, offering a more rounded approach to sugar management.\n\nProduced under strict pharmaceutical quality benchmarks, TENELIGOLD PM 1000 works to sharpen the body's response to insulin, prompt insulin release in step with rising glucose, and rein in the liver's excess sugar output. It's typically brought into a treatment plan once lifestyle changes and single-drug therapy no longer keep blood sugar within target range.\n\nComposition\n\nEach sustained-release tablet delivers:\n\nTeneligliptin – 20 mg\nPioglitazone – 15 mg\nMetformin Hydrochloride (Sustained Release) – 1000 mg\n\nDosage Form: Sustained Release Tablets\n\nHow TENELIGOLD PM 1000 Works\n\nThis tablet pairs three well-known antidiabetic molecules so their effects complement one another.\n\n1. Teneligliptin 20 mg\n\nA DPP-4 inhibitor, Teneligliptin raises the body's incretin hormone activity, which in turn:\n\nTriggers insulin output only when glucose levels are elevated\nCurbs glucagon release\nFlattens the post-meal blood sugar rise\nKeeps hypoglycemia risk low\n\n2. Pioglitazone 15 mg\n\nBelonging to the Thiazolidinedione (TZD) family, Pioglitazone:\n\nSharpens the body's sensitivity to insulin\nHelps muscle tissue take up and use glucose more effectively\nCuts down insulin resistance\nAids sustained glycemic management over time\n\n3. Metformin SR 1000 mg\n\nA Biguanide-class agent, Metformin SR:\n\nSlows the liver's glucose output\nLimits how much glucose the intestines absorb\nBoosts insulin responsiveness\nDelivers steady blood sugar control across the day\n\nBecause it's released gradually, the sustained-release format is also gentler on the stomach than immediate-release versions.\n\nBenefits of TENELIGOLD PM 1000\n\nWell-Rounded Blood Sugar Control The three-pronged formula works to steady both fasting glucose and the spikes that follow meals.\n\nStronger HbA1c Improvement Used appropriately, this combination therapy may lower HbA1c more than a single-agent approach would.\n\nSharper Insulin Response Pioglitazone's role in easing insulin resistance means the insulin the body produces (or receives) does more work.\n\nSteady, All-Day Coverage Metformin SR's gradual release keeps blood sugar levels more consistent throughout the day.\n\nOne Tablet, Three Medicines Combining proven antidiabetic drugs into a single pill can make treatment simpler and support better adherence.\n\nA Foundation for Long-Term Care Sustained glycemic control, paired with healthy lifestyle habits, may help lower the risk of diabetes-related complications down the line.\n\nIndications\n\nTENELIGOLD PM 1000 is intended as an add-on to diet and exercise for improving blood sugar control in adults with Type 2 Diabetes Mellitus, particularly where a physician determines combination therapy is the right course.\n\nIt is not meant for Type 1 Diabetes Mellitus or diabetic ketoacidosis.\n\nKey Features\nTriple-combination antidiabetic tablet\nSustained-release Metformin component\nSupports both fasting and post-meal glucose control\nImproves insulin sensitivity\nEncourages glucose-responsive insulin release\nLowers hepatic glucose output\nOnce-daily dosing convenience, as prescribed\nManufactured to rigorous quality standards\nSuited to long-term diabetes management under medical guidance\nWho May Benefit?\n\nPhysicians may consider TENELIGOLD PM 1000 for adult T2DM patients who:\n\nContinue to have unmanaged blood sugar despite two-drug therapy\nNeed better HbA1c outcomes\nShow marked insulin resistance\nRequire broader glycemic coverage\nWould benefit from a sustained-release metformin option\n\nEvery treatment decision should be tailored by the prescribing doctor.\n\nDirections for Use\nTake exactly as directed by your physician.\nSwallow the tablet whole with water.\nNever crush, chew, or split the sustained-release tablet.\nTaking it with food is generally advised to ease stomach upset.\nPair the medicine with your prescribed diet and exercise plan for best results.\nPossible Side Effects\n\nAs with any medicine, TENELIGOLD PM 1000 can cause side effects, though not everyone will experience them.\n\nCommonly reported:\n\nNausea\nDiarrhea\nStomach discomfort\nHeadache\nSlight weight gain\nSwelling in the extremities (peripheral edema), linked mainly to pioglitazone\n\nLess common but serious:\n\nLactic acidosis (a metformin-related risk, more likely in vulnerable patients)\nWorsening heart failure (associated with pioglitazone in select patients)\nAllergic reactions\nAbnormal liver function\n\nSeek urgent medical care if severe weakness, breathing difficulty, chest pain, or ongoing abdominal pain develops.\n\nPrecautions\n\nTell your healthcare provider before starting TENELIGOLD PM 1000 if you have any of the following:\n\nKidney disease\nLiver disease\nHeart failure\nBladder cancer, present or past\nPancreatitis\nVitamin B12 deficiency\nSevere dehydration\nAn upcoming surgery or imaging test involving iodinated contrast dye\n\nRoutine checks of blood glucose, HbA1c, kidney function, liver function, and related markers are advised throughout treatment.\n\nStorage Instructions\nStore below 30°C.\nKeep away from moisture and direct sunlight.\nLeave in the original packaging.\nStore out of children's reach.\nWhy Choose TENELIGOLD PM 1000?\n\nTENELIGOLD PM 1000 brings three established antidiabetic medicines together in one sustained-release tablet, giving physicians a way to simplify a patient's regimen while still addressing multiple facets of Type 2 Diabetes. Through its complementary mechanisms, it offers a well-rounded route to blood sugar control for suitably selected adult patients under medical supervision.\n\nFrequently Asked Questions (FAQs)\n\nWhat is TENELIGOLD PM 1000 used for? It's prescribed to help manage Type 2 Diabetes Mellitus in adults whose blood sugar needs combination therapy alongside diet and exercise.\n\nIs TENELIGOLD PM 1000 meant to be taken every day? Yes, exactly as your physician prescribes. Don't adjust the dose on your own.\n\nCan TENELIGOLD PM 1000 lead to low blood sugar? Taken alone, the hypoglycemia risk is generally low, though it can rise if combined with insulin or sulfonylureas.\n\nCan I stop the medicine once my sugar levels normalize? No — diabetes is a long-term condition. Keep taking the medicine unless your doctor says otherwise.\n\nIs this medicine right for Type 1 Diabetes? No. It's formulated only for adults with Type 2 Diabetes Mellitus.\n\nShould TENELIGOLD PM 1000 be taken with food? Yes, taking it with meals is generally recommended to reduce stomach-related side effects.\n\nDoes it help bring down HbA1c? Yes — used as directed alongside lifestyle changes, it can support meaningful HbA1c improvement.\n\nPrescription only – consult your doctor.\n\n", "price": 385.0, "discountamount": 95.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2473, "imageuri": "https://productimages.withfloats.com/actual/6a5de55cdc76c6268e3fe287.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a5de55cdc76c6268e3fe287.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-20T09:07:38.732Z", "updatedon": "2026-07-20T09:07:38.732Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//teneligliptin-20mg-pioglitazone-15mg-metformin-hydrochloride-sustained-release-1000mg-tablets/2473", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PM 1000", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a460bf90c11f3c74a816c87", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "methylprednisolone sodium succinate for injection usp", "description": "Methylprednisolone Sodium Succinate for Injection USP is a fast-acting corticosteroid administered intravenously or intramuscularly to control severe inflammation, allergic reactions, and autoimmune flare-ups. It works by rapidly suppressing the immune and inflammatory response and is used in hospital or clinical settings for acute conditions such as severe asthma attacks, anaphylaxis, autoimmune disease flares, and spinal cord injury protocols. It is a Schedule H prescription drug administered only under medical supervision.\n\nWhat Is Methylprednisolone Sodium Succinate for Injection USP?\n\nMethylprednisolone Sodium Succinate for Injection USP is a water-soluble, injectable corticosteroid used for rapid control of severe inflammatory, allergic, and autoimmune conditions. It is manufactured to United States Pharmacopeia (USP) standards and is typically administered by a healthcare professional via intravenous (IV) or intramuscular (IM) route when fast, high-potency anti-inflammatory or immunosuppressive action is required — situations where oral steroids act too slowly or oral intake isn't feasible.\n\nHow It Works\n\nMethylprednisolone sodium succinate is a synthetic glucocorticoid that acts rapidly once reconstituted and injected.\n\n\nBinds glucocorticoid receptors – enters cells and binds intracellular receptors that regulate inflammatory gene expression.\nSuppresses inflammatory mediators – reduces production of prostaglandins, leukotrienes, and cytokines responsible for swelling, redness, and pain.\nStabilizes cell membranes – reduces capillary permeability, limiting fluid leakage and tissue swelling at the site of inflammation.\nDampens immune overactivity – suppresses lymphocyte and macrophage activity, calming autoimmune or allergic overreactions.\nDelivers rapid systemic action – because it's water-soluble and given IV/IM, onset of anti-inflammatory effect is significantly faster than oral steroids.\n\n\nClinical Indications\n\nConditionWhy Methylprednisolone Injection Is UsedSevere Allergic Reactions / AnaphylaxisRapidly controls swelling, airway inflammation, and allergic cascadeAcute Asthma Exacerbation / COPD FlareReduces airway inflammation when inhalers alone are insufficientAutoimmune Disease Flares (Lupus, Rheumatoid Arthritis)High-dose pulse therapy to control acute flaresSpinal Cord Injury (acute, under specialist protocol)Used in specific clinical protocols to limit secondary inflammationSevere Dermatologic ReactionsControls widespread inflammatory skin reactionsPost-Transplant / Organ Rejection ManagementUsed as part of immunosuppressive regimens\n\nDosage & Administration\n\nParameterRecommendationTypical Adult Dose10–40 mg IV, may range up to 30 mg/kg in high-dose pulse therapy for specific conditionsRouteIntravenous (IV) injection/infusion or Intramuscular (IM) injectionFrequencyAs directed by the treating physician; often single dose or short tapering courseReconstitutionMust be reconstituted only with the accompanying diluent as per product insert, immediately before useAdministration SettingHospital, clinic, or under direct medical/nursing supervision onlyDurationShort-term acute use unless otherwise directed; long-term use requires specialist monitoring\n\nThis is a Schedule H prescription-only medicine. Dosage must be determined and administered by a qualified healthcare professional.\n\nPrecautions\n\n\nTo be administered only by or under the supervision of a healthcare professional.\nNot for self-administration or home use.\nInform the doctor of any active infections, as corticosteroids can mask symptoms and suppress immune response.\nUse with caution in patients with diabetes, hypertension, peptic ulcer disease, osteoporosis, or psychiatric history.\nAvoid live vaccines during treatment due to immunosuppressive effects.\nPregnant or breastfeeding patients should use only under strict medical guidance.\nAbrupt discontinuation after prolonged use should be avoided; tapering may be required as advised by the physician.\n\n\nPossible Side Effects\n\nMost side effects relate to the drug's systemic corticosteroid action and are monitored by the administering clinician:\n\n\nElevated blood sugar levels\nFluid retention, increased blood pressure\nMood changes, insomnia, or restlessness\nNausea or gastrointestinal discomfort\nIncreased susceptibility to infection\nInjection site reactions\n\n\nSerious side effects requiring immediate medical attention include severe allergic reaction, signs of infection (fever, chills), significant mood or behavioral changes, unusual swelling, or vision disturbances. Because this is administered in a clinical setting, the healthcare team monitors for these actively.\n\nComparison: Methylprednisolone vs. Other Injectable Corticosteroids\n\nDrugRelative PotencyCommon Use CaseRouteMethylprednisolone Sodium SuccinateHighAcute severe inflammation, autoimmune flaresIV/IMHydrocortisone Sodium SuccinateLowerAdrenal insufficiency, milder acute inflammationIV/IMDexamethasone Sodium PhosphateVery HighCerebral edema, severe allergic/inflammatory conditionsIV/IMBetamethasone Sodium PhosphateHighAllergic and inflammatory conditions, fetal lung maturityIV/IMTriamcinolone AcetonideModerate (depot)Localized/intra-articular inflammationIM/Intra-articular\n\nKey Statistics\n\nStatisticData PointSourceOnset of anti-inflammatory action after IV administrationWithin 1–2 hours for measurable effectClinical pharmacology references, USP monographUse in acute severe asthma protocolsRecommended as part of systemic corticosteroid therapy in emergency guidelinesGlobal Initiative for Asthma (GINA) guidelinesHospital use in anaphylaxis managementIncluded as an adjunct in anaphylaxis treatment protocols alongside epinephrineWorld Allergy Organization guidanceHigh-dose pulse therapy applicationUsed in select autoimmune flare protocols under specialist supervisionPublished rheumatology treatment guidelines\n\nExpert Insight\n\n[Insert verified physician or clinical pharmacologist commentary here — Claude has not fabricated a quote. Recommend sourcing a short, attributable statement from a Steris Healthcare medical advisor or a cited clinical guideline before publishing.]\n\nConclusion\n\nMethylprednisolone Sodium Succinate for Injection USP is a high-potency, fast-acting corticosteroid reserved for situations where rapid control of severe inflammation, allergic reaction, or autoimmune flare is essential. Administered only under clinical supervision, it plays a critical role in emergency and hospital-based treatment protocols — from anaphylaxis and acute asthma to autoimmune disease management. As a Schedule H medicine, it must never be self-administered; dosage, route, and duration should always be determined by a qualified physician based on the patient's condition. For pharmacopoeia-grade quality and reliable hospital supply, source this injection through a WHO-GMP certified manufacturer.\n\nPrescription only – consult your doctor.\n\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n\n1. What is methylprednisolone sodium succinate injection used for?\nIt is used to rapidly control severe inflammation, allergic reactions, and autoimmune flare-ups, such as anaphylaxis, acute asthma attacks, and lupus or rheumatoid arthritis flares. It is administered under medical supervision in hospital or clinical settings.\n\n2. Is methylprednisolone injection a steroid?\nYes, it is a synthetic corticosteroid (glucocorticoid) that works by suppressing inflammatory and immune responses in the body, providing rapid relief in acute, severe conditions.\n\n3. How is methylprednisolone sodium succinate injection given?\nIt is given by a healthcare professional via intravenous (IV) or intramuscular (IM) injection, after being reconstituted with the correct diluent immediately before administration. It is not for self-injection or home use.\n\n4. How fast does methylprednisolone injection start working?\nBecause it is water-soluble and given directly into the bloodstream or muscle, measurable anti-inflammatory effects typically begin within one to two hours of administration.\n\n5. What are the side effects of methylprednisolone injection?\nCommon effects include elevated blood sugar, fluid retention, mood changes, and increased infection risk. These are monitored by the administering healthcare team, and serious reactions are managed promptly in a clinical setting.\n\n6. Is methylprednisolone sodium succinate injection available without a prescription?\nNo. It is a Schedule H prescription-only medicine that must be administered by or under the direct supervision of a qualified healthcare professional.\n\n7. What is the difference between methylprednisolone and dexamethasone injection?\nBoth are injectable corticosteroids, but dexamethasone has a longer duration of action and higher relative potency, while methylprednisolone is often preferred for acute pulse therapy and shorter-acting systemic control. The choice depends on the clinical scenario and physician judgment.\n\n8. Can methylprednisolone injection be used in pregnancy?\nIt may be used in pregnancy only when clearly necessary and under strict medical supervision, as the treating physician will weigh the benefits against potential risks for the specific condition being treated.", "price": 47.0, "discountamount": 19.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2465, "imageuri": "https://productimages.withfloats.com/actual/6a460bfb9f5529389b8b15b8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a460bfb9f5529389b8b15b8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-02T06:58:01.631Z", "updatedon": "2026-07-02T06:58:01.631Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//methylprednisolone-sodium-succinate-for-injection-usp/2465", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METHIDENOSOLE 40 INJ", "category": "GENERAL RANGE", "tags": [ "methylprednisolone sodium succinate injection uses", "methylprednisolone sodium succinate injection uses in hindi", "methylprednisolone sodium succinate", "methylprednisolone sodium succinate injection", "inj methylprednisolone sodium succinate", "methylprednisolone sodium succinate uses in hindi", "methylprednisolone sodium succinate for injection", "methylprednisolone sodium succinate injection usp" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a43bee2d208c802be053f9d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg", "description": "Managing type 2 diabetes often requires more than a single medication to achieve long-term blood sugar control. Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is a triple-combination prescription medicine formulated to help adults with type 2 diabetes maintain healthy glucose levels when diet, exercise, and single-drug therapy are not enough.\n\nThis advanced combination works through three different mechanisms to improve insulin sensitivity, reduce glucose production by the liver, and enhance the body's natural insulin response after meals. Because of its multi-action approach, it is frequently prescribed by healthcare professionals for patients requiring comprehensive glycemic control.\n\nIf you are searching for Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg, this guide covers everything you need to know—including how it works, benefits, dosage information, side effects, precautions, storage, and frequently asked questions.\n\nWhat is Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg?\n\nSitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is a prescription oral anti-diabetic medicine used to manage Type 2 Diabetes Mellitus. It combines three clinically proven medicines into one convenient tablet to provide better blood sugar management throughout the day.\n\nThe formulation contains:\n\nSitagliptin 100 mg – A DPP-4 inhibitor that increases incretin hormones to improve insulin secretion.\nMetformin Hydrochloride 1000 mg Sustained Release – A biguanide that lowers glucose production by the liver and improves insulin sensitivity.\nPioglitazone 15 mg – A thiazolidinedione that enhances the body's response to insulin.\n\nTogether, these ingredients target multiple causes of high blood sugar, helping patients achieve better diabetes control while reducing the need for multiple separate medications.\n\nHow Does Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg Work?\n\nThis triple-combination tablet works through complementary mechanisms:\n\n1. Sitagliptin\n\nSitagliptin inhibits the DPP-4 enzyme, allowing incretin hormones to remain active longer. These hormones increase insulin release after meals and reduce excess glucagon production.\n\n2. Metformin SR\n\nMetformin Sustained Release decreases glucose production in the liver, reduces intestinal glucose absorption, and improves insulin sensitivity without causing excessive insulin release.\n\n3. Pioglitazone\n\nPioglitazone improves insulin sensitivity in muscle and fat tissues, enabling cells to utilize glucose more effectively.\n\nThe combination helps maintain consistent blood sugar levels throughout the day while lowering both fasting and post-meal glucose.\n\nWhy is This Triple Combination Important?\n\nType 2 diabetes progresses over time, making it difficult for many patients to control blood sugar using a single medication. A triple therapy offers several advantages:\n\nBetter HbA1c reduction\nMultiple mechanisms of action\nReduced insulin resistance\nImproved post-meal glucose control\nLower fasting blood sugar\nSimplified treatment with one tablet\nImproved medication adherence\nReduced need for additional medications\n\nHealthcare providers often prescribe this combination when dual therapy no longer provides adequate glucose control.\n\nKey Benefits of Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg\nExcellent Blood Sugar Control\n\nThe medicine helps reduce both fasting and postprandial blood glucose levels effectively.\n\nTriple Mechanism of Action\n\nEach ingredient targets a different pathway involved in diabetes, resulting in more comprehensive glycemic control.\n\nImproved Insulin Sensitivity\n\nPioglitazone increases insulin responsiveness, helping the body utilize glucose more efficiently.\n\nReduced Liver Glucose Production\n\nMetformin decreases glucose release from the liver, preventing unnecessary increases in blood sugar.\n\nSupports Long-Term Diabetes Management\n\nRegular use, alongside lifestyle modifications, contributes to improved HbA1c levels and reduced diabetes-related complications.\n\nConvenient Once-Daily Regimen\n\nCombining three medicines into a single tablet improves treatment convenience and supports better compliance.\n\nWho May Benefit from This Medicine?\n\nHealthcare professionals may prescribe this medication for adults with Type 2 Diabetes who:\n\nHave uncontrolled blood sugar despite dual therapy\nRequire triple oral anti-diabetic therapy\nHave elevated HbA1c levels\nNeed improved insulin sensitivity\nPrefer fewer tablets in their treatment plan\nAre following dietary and exercise recommendations but require additional glucose control\n\nThis medicine is not intended for Type 1 Diabetes or diabetic ketoacidosis.\n\nHow to Take Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg\n\nAlways follow your physician's instructions.\n\nGeneral recommendations include:\n\nTake once daily or as prescribed.\nSwallow the tablet whole.\nDo not crush, split, or chew the sustained-release tablet.\nTake with food to reduce stomach discomfort.\nTake it at the same time each day.\nContinue exercising and following a diabetic meal plan.\n\nNever stop treatment without consulting your healthcare provider.\n\nPossible Side Effects\n\nLike all prescription medicines, this combination may cause side effects, although not everyone experiences them.\n\nCommon side effects include:\n\nNausea\nStomach discomfort\nDiarrhea\nHeadache\nUpper respiratory infection\nWeight gain\nSwelling of feet or ankles\nMuscle aches\nDizziness\n\nSeek immediate medical attention if you experience:\n\nSevere allergic reaction\nPersistent vomiting\nDifficulty breathing\nSevere abdominal pain\nUnusual fatigue\nYellowing of skin or eyes\nSymptoms of lactic acidosis\nSigns of heart failure, such as rapid weight gain or shortness of breath\nPrecautions Before Using This Medicine\n\nInform your healthcare provider if you have:\n\nKidney disease\nLiver disease\nHeart failure\nBladder cancer history\nPancreatitis\nSevere dehydration\nAlcohol dependence\nVitamin B12 deficiency\nPlanned surgery or imaging with contrast dye\n\nWomen who are pregnant or breastfeeding should use this medicine only under medical supervision.\n\nDrug Interactions\n\nTell your doctor about all medicines you take, including:\n\nInsulin\nSulfonylureas\nDiuretics\nCorticosteroids\nThyroid medicines\nBlood pressure medicines\nRifampicin\nAlcohol\nCimetidine\nCertain antifungal medicines\n\nProper medication review helps minimize interaction risks.\n\nLifestyle Tips for Better Diabetes Control\n\nMedicine works best when combined with healthy lifestyle habits.\n\nRecommended practices include:\n\nFollow a balanced diabetic diet.\nExercise for at least 30 minutes most days.\nMonitor blood sugar regularly.\nMaintain a healthy body weight.\nStay hydrated.\nAvoid smoking.\nLimit alcohol intake.\nGet regular HbA1c tests.\nManage stress effectively.\nAttend routine medical check-ups.\nStorage Instructions\n\nStore the tablets:\n\nBelow 25°C\nIn a cool, dry place\nAway from moisture and direct sunlight\nIn the original packaging\nOut of reach of children and pets\n\nDo not use expired medicine.\n\nWhy Healthcare Professionals Choose This Triple Combination\n\nDoctors frequently recommend Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg because it addresses multiple aspects of diabetes management in a single formulation. By improving insulin secretion, reducing hepatic glucose production, and enhancing insulin sensitivity, it provides comprehensive glycemic control while simplifying treatment. When combined with a healthy lifestyle and regular medical follow-up, it can support long-term diabetes management and help reduce the risk of complications associated with uncontrolled blood sugar.\n\nConclusion\n\nSitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is an effective prescription medication designed for adults with Type 2 Diabetes Mellitus who require stronger blood sugar management than single or dual therapy can provide. Its triple-action formula offers improved glycemic control, better insulin utilization, and convenient once-daily dosing. While highly effective, it should always be used under the guidance of a qualified healthcare professional, together with a balanced diet, regular physical activity, and routine blood sugar monitoring for the best long-term outcomes.\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n1. What is Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg used for?\n\nIt is prescribed to help adults with Type 2 Diabetes Mellitus control blood sugar when lifestyle changes and other oral medicines do not provide adequate glycemic control.\n\n2. How does this triple-combination tablet work?\n\nIt combines three medicines that increase insulin release after meals, reduce glucose production by the liver, and improve the body's sensitivity to insulin, resulting in better overall blood sugar control.\n\n3. Can this medicine be taken once daily?\n\nYes. Many patients take it once daily, but the exact dosage and timing should always follow the prescribing doctor's instructions.\n\n4. Should I take this tablet with food?\n\nYes. Taking it with meals helps reduce stomach-related side effects associated with metformin and improves tolerability.\n\n5. Can this medicine cure diabetes?\n\nNo. It helps control blood sugar levels but does not cure Type 2 Diabetes. Long-term treatment, healthy eating, exercise, and regular monitoring remain essential.\n\n6. What should I do if I miss a dose?\n\nTake the missed dose as soon as you remember unless it is nearly time for your next scheduled dose. Do not take two doses together to make up for a missed dose.\n\n7. Can this medicine cause low blood sugar?\n\nOn its own, the risk is relatively low. However, the likelihood increases when it is used with insulin or sulfonylurea medicines, or if meals are skipped.\n\n8. Is this medicine safe for patients with kidney disease?\n\nPatients with kidney impairment require medical evaluation before using this medicine, particularly because metformin may not be suitable in severe kidney dysfunction.\n\n9. Can I drink alcohol while taking this medication?\n\nAlcohol intake should be limited or avoided, as excessive consumption may increase the risk of serious side effects, including lactic acidosis.\n\n10. Who should not use Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg?\n\nIt should not be used without medical advice by individuals with Type 1 Diabetes, diabetic ketoacidosis, severe kidney disease, certain liver conditions, or a history of serious hypersensitivity to any of its ingredients. Always consult your healthcare provider before starting treatment.", "price": 243.0, "discountamount": 73.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2462, "imageuri": "https://productimages.withfloats.com/actual/6a43bee3de301bd6de277db2.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a43bee3de301bd6de277db2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-30T13:04:34Z", "updatedon": "2026-06-30T13:04:34Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-100mg-metformin-hydrochloride-1000mg-sustained-release-pioglitazone-15-mg/2462", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN 3D 1000", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a153f150f3a1ec7df62ff41", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg", "description": "Glimepiride Voglibose and Metformin Hydrochloride Tablets are a combination anti-diabetic medicine used for the effective management of Type 2 Diabetes Mellitus. This triple-action formulation helps control blood sugar levels through multiple mechanisms, making it highly beneficial for patients who are unable to achieve adequate glucose control with single-drug therapy.\n\nType 2 diabetes is a chronic metabolic disorder that affects the body’s ability to regulate blood sugar properly. Uncontrolled diabetes can lead to severe health complications such as heart disease, kidney damage, nerve disorders, vision problems, and poor circulation. This combination therapy is designed to provide comprehensive glycemic control by improving insulin action, reducing glucose production, and slowing carbohydrate absorption.\n\nDoctors commonly prescribe Glimepiride Voglibose and Metformin Hydrochloride Tablets to support long-term diabetes management and reduce the risk of diabetes-related complications.\n\nWhat are Glimepiride Voglibose and Metformin Hydrochloride Tablets?\n\nThis medicine contains three active ingredients that work together to maintain healthy blood sugar levels:\n\nGlimepiride – A sulfonylurea anti-diabetic agent\nVoglibose – An alpha-glucosidase inhibitor\nMetformin Hydrochloride – A biguanide anti-diabetic medicine\n\nEach ingredient targets a different pathway involved in blood sugar regulation, offering a more effective approach for diabetes control.\n\nKey Benefits of Glimepiride Voglibose and Metformin Hydrochloride Tablets\n1. Helps Control Blood Sugar Levels Effectively\n\nThis combination medicine provides comprehensive glucose management throughout the day, especially after meals when blood sugar spikes are common.\n\n2. Improves Insulin Function\n\nGlimepiride stimulates the pancreas to release insulin, helping the body utilize glucose more efficiently.\n\n3. Reduces Excess Glucose Production\n\nMetformin decreases glucose production in the liver and improves insulin sensitivity, making it easier for the body to use available insulin.\n\n4. Controls Post-Meal Sugar Spikes\n\nVoglibose delays carbohydrate digestion and absorption in the intestine, helping prevent sudden increases in blood sugar after meals.\n\n5. Supports Long-Term Diabetes Management\n\nRegular use helps reduce the risk of complications associated with uncontrolled diabetes, such as kidney disease, nerve damage, and cardiovascular problems.\n\nHow Glimepiride Voglibose and Metformin Hydrochloride Tablets Work\n\nThis triple-drug combination works through complementary mechanisms:\n\nGlimepiride\n\nGlimepiride stimulates beta cells in the pancreas to release insulin. Increased insulin helps lower blood glucose levels by allowing sugar to enter body cells for energy use.\n\nVoglibose\n\nVoglibose inhibits enzymes responsible for breaking down complex carbohydrates into simple sugars. This slows glucose absorption from food and prevents rapid post-meal blood sugar rises.\n\nMetformin Hydrochloride\n\nMetformin reduces glucose production by the liver and enhances insulin sensitivity in muscles and tissues. It also helps decrease intestinal glucose absorption.\n\nTogether, these actions provide balanced and effective blood sugar control throughout the day.\n\nUses of Glimepiride Voglibose and Metformin Hydrochloride Tablets\n\nThis medicine is primarily prescribed for:\n\nType 2 Diabetes Mellitus\nPoorly controlled blood sugar levels\nPostprandial hyperglycemia (high blood sugar after meals)\nDiabetes management in overweight individuals\nCombination therapy when diet and exercise alone are insufficient\n\nIt is usually recommended along with proper diet, exercise, and lifestyle modifications.\n\nDosage and Administration\n\nThe dosage depends on blood sugar levels, patient response, and physician recommendations.\n\nGeneral Usage Guidelines\nUsually taken once or twice daily with meals\nSwallow tablets whole with water\nTake at the same time each day for consistent control\nFollow dietary advice strictly during treatment\n\nDo not skip meals while taking this medicine, as it may increase the risk of low blood sugar.\n\nPatients should regularly monitor blood glucose levels during therapy.\n\nPossible Side Effects\n\nLike any medication, Glimepiride Voglibose and Metformin Hydrochloride Tablets may cause side effects in some individuals.\n\nCommon Side Effects\nNausea\nDiarrhea\nAbdominal discomfort\nGas or bloating\nHeadache\nDizziness\nLow Blood Sugar Symptoms (Hypoglycemia)\n\nGlimepiride may occasionally cause low blood sugar, especially if meals are skipped.\n\nSymptoms include:\n\nSweating\nShaking\nHunger\nWeakness\nFast heartbeat\nConfusion\n\nKeeping a quick sugar source such as glucose tablets or juice is recommended.\n\nRare but Serious Side Effects\nSevere allergic reactions\nLactic acidosis (rare but serious with metformin)\nLiver-related issues\n\nImmediate medical attention should be sought if serious symptoms occur.\n\nPrecautions and Warnings\n\nBefore using this medicine, patients should inform their doctor about any existing medical conditions.\n\nImportant Precautions\nAvoid excessive alcohol consumption\nUse cautiously in kidney or liver disease\nRegular monitoring of kidney function may be required\nElderly patients may need dose adjustments\nInform the doctor before surgery or major illness\nPregnant or breastfeeding women should use only if prescribed\n\nMaintaining proper meal timing and lifestyle habits is important for safe and effective diabetes management.\n\nWho Should Use Glimepiride Voglibose and Metformin Hydrochloride Tablets?\n\nThis medicine is suitable for:\n\nAdults with Type 2 Diabetes Mellitus\nPatients with uncontrolled post-meal glucose levels\nIndividuals requiring combination anti-diabetic therapy\nPatients not achieving adequate control with single medicines\nOverweight diabetic individuals needing insulin sensitivity improvement\n\nA healthcare professional will determine the appropriate treatment plan based on medical history and glucose profile.\n\nWhy Choose Glimepiride Voglibose and Metformin Hydrochloride Tablets?\n\nThis combination therapy is preferred because it targets multiple aspects of diabetes simultaneously.\n\nAdvantages Include:\nTriple-action blood sugar control\nBetter post-meal glucose management\nImproved insulin utilization\nConvenient combination therapy\nReduces need for multiple separate medicines\nSupports long-term metabolic health\n\nIt offers comprehensive diabetes management in a single tablet formulation.\n\nLifestyle Tips for Better Diabetes Control\n\nAlong with medication, healthy lifestyle changes significantly improve diabetes management.\n\nRecommended Habits\nFollow a balanced diabetic diet\nExercise regularly\nMonitor blood sugar consistently\nMaintain healthy body weight\nAvoid smoking and excessive alcohol\nStay hydrated\nGet regular medical checkups\n\nThese habits help improve treatment effectiveness and reduce complications.\n\nStorage Instructions\nStore in a cool, dry place\nProtect from moisture and direct sunlight\nKeep out of reach of children\nUse only before expiry date\nBuyer Intent Summary\n\nIf you are searching for an effective combination medicine for Type 2 Diabetes management, Glimepiride Voglibose and Metformin Hydrochloride Tablets provide advanced blood sugar control through a triple-action mechanism. This medicine helps reduce fasting and post-meal sugar levels while improving insulin function and metabolic balance.", "price": 262.0, "discountamount": 79.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2428, "imageuri": "https://productimages.withfloats.com/actual/6a153f17d73bfed7b4b4181f.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a153f17d73bfed7b4b4181f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-26T06:35:01.356Z", "updatedon": "2026-05-26T06:35:01.356Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg/2428", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "DIABETIC RANGE", "tags": [ "glimepiride voglibose and metformin hydrochloride tablets", "metformin glimepiride voglibose", "glimepiride voglibose metformin", "tab metformin glimepiride voglibose", "glimepiride voglibose and metformin hydrochloride tablets uses", "metformin hydrochloride glimepiride voglibose", "metformin glimepiride voglibose 0.3", "glimepiride voglibose and metformin sr tablets", "glimepiride voglibose and metformin", "metformin glimepiride voglibose uses", "metformin glimepiride voglibose combination", "metformin glimepiride voglibose 0.2", "metformin glimepiride voglibose dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a06f0051c45b26e830ddf29", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "dapagliflozin 10 vildagliptin 100 metformin 1000", "description": "Managing type 2 diabetes effectively requires the right combination of medicines, healthy eating habits, and an active lifestyle. Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets is a powerful triple-combination anti-diabetic medication designed to help control blood sugar levels in adults suffering from type 2 diabetes mellitus. This advanced formulation combines three clinically trusted medicines in one tablet to improve glycemic control and support long-term diabetic management.\n\nThis combination is commonly prescribed when blood sugar levels are not adequately controlled with a single medicine or dual therapy. It helps patients achieve better glucose regulation while reducing the risk of diabetes-related complications.\n\nWhat is Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets?\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets is a combination medication used for the treatment of Type 2 Diabetes Mellitus. It contains:\n\nDapagliflozin 10 mg\nVildagliptin SR 100 mg\nMetformin SR 1000 mg\n\nEach ingredient works through a different mechanism to provide comprehensive blood sugar control.\n\nThis medicine is generally recommended along with proper diet and exercise to improve overall diabetic management and reduce insulin resistance.\n\nComposition of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\n1. Dapagliflozin 10 mg\n\nDapagliflozin belongs to the SGLT2 inhibitor class of medicines. It works by removing excess glucose from the body through urine. This helps lower blood sugar levels naturally.\n\n2. Vildagliptin SR 100 mg\n\nVildagliptin is a DPP-4 inhibitor that increases incretin hormone levels in the body. These hormones help regulate insulin secretion and reduce glucose production by the liver.\n\n3. Metformin SR 1000 mg\n\nMetformin is one of the most trusted anti-diabetic medicines worldwide. It reduces glucose production in the liver and improves insulin sensitivity in the body.\n\nThe sustained-release (SR) formulation ensures gradual release of medicine for long-lasting action and better patient compliance.\n\nHow Do Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets Work?\n\nThis triple combination provides multidimensional control over blood sugar levels.\n\nDapagliflozin Works By:\nRemoving excess sugar through urine\nLowering fasting blood glucose\nSupporting weight management\nVildagliptin Works By:\nIncreasing insulin release after meals\nReducing glucagon secretion\nImproving pancreatic function\nMetformin Works By:\nReducing liver glucose production\nImproving insulin sensitivity\nLowering intestinal glucose absorption\n\nTogether, these medicines help maintain stable blood glucose levels throughout the day.\n\nBenefits of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\nEffective Blood Sugar Control\n\nThe combination targets multiple pathways involved in diabetes, helping achieve better glycemic control.\n\nReduced Risk of Diabetes Complications\n\nProper diabetes management lowers the risk of:\n\nKidney problems\nNerve damage\nHeart disease\nVision complications\nWeight Management Support\n\nDapagliflozin helps remove excess glucose, which may contribute to mild weight reduction in some patients.\n\nImproved Insulin Sensitivity\n\nMetformin enhances insulin utilization by body tissues.\n\nBetter Patient Compliance\n\nThree medicines in a single tablet reduce pill burden and simplify treatment.\n\nSustained Release Formula\n\nThe SR formulation provides extended therapeutic action and minimizes fluctuations in blood sugar levels.\n\nUses of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\n\nThis medicine is mainly prescribed for:\n\nType 2 Diabetes Mellitus\nUncontrolled diabetes despite dual therapy\nPatients requiring triple-drug glucose control\nImproving HbA1c levels\nManaging post-meal blood sugar spikes\n\nIt is generally not recommended for type 1 diabetes unless specifically advised by a healthcare professional.\n\nWho Can Take This Medicine?\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg tablets may be suitable for:\n\nAdults diagnosed with type 2 diabetes\nPatients with insulin resistance\nIndividuals requiring combination diabetic therapy\nPatients seeking convenient once-daily diabetic medication\n\nAlways use this medicine under medical supervision.\n\nDosage and Administration\nTake the tablet exactly as prescribed by your doctor.\nUsually taken once daily with meals.\nSwallow the tablet whole with water.\nDo not crush or chew sustained-release tablets.\nFollow dietary recommendations for best results.\n\nDosage may vary depending on blood sugar levels and patient response.\n\nPossible Side Effects\n\nLike all medicines, Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg tablets may cause some side effects.\n\nCommon Side Effects\nNausea\nDiarrhea\nFrequent urination\nHeadache\nStomach discomfort\nWeakness\nLess Common Side Effects\nUrinary tract infections\nGenital fungal infections\nDizziness\nLow blood sugar (especially with other anti-diabetic medicines)\nSerious Side Effects\n\nSeek immediate medical attention if you experience:\n\nSevere dehydration\nDifficulty breathing\nSevere abdominal pain\nSigns of allergic reaction\nPersistent vomiting\n\nMost side effects are mild and improve as the body adjusts to the medicine.\n\nPrecautions and Warnings\n\nBefore taking this medicine, inform your doctor if you have:\n\nKidney disease\nLiver disorders\nHeart disease\nHistory of pancreatitis\nDehydration issues\nAlcohol dependence\nImportant Precautions\nStay hydrated while taking dapagliflozin.\nMonitor blood sugar regularly.\nAvoid excessive alcohol consumption.\nFollow a diabetic-friendly diet.\n\nPregnant and breastfeeding women should consult a doctor before use.\n\nDrug Interactions\n\nThis medicine may interact with:\n\nInsulin\nSulfonylureas\nDiuretics\nBlood pressure medicines\nCorticosteroids\n\nAlways inform your doctor about all medications and supplements you are taking.\n\nStorage Instructions\nStore in a cool and dry place.\nKeep away from direct sunlight and moisture.\nStore below recommended room temperature.\nKeep out of reach of children.\n\nProper storage ensures medicine effectiveness and safety.\n\nWhy Choose Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets?\n\nThis advanced antidiabetic combination offers:\n\nTriple-action diabetes management\nLong-lasting blood sugar control\nConvenient dosing\nImproved patient adherence\nComprehensive glycemic regulation\n\nIt is widely preferred by healthcare professionals for patients requiring strong and reliable diabetic treatment.\n\nLifestyle Tips for Better Diabetes Management\n\nAlong with medication, patients should:\n\nMaintain a balanced diabetic diet\nExercise regularly\nMonitor blood glucose levels\nStay hydrated\nAvoid sugary foods\nFollow regular medical checkups\n\nHealthy lifestyle changes significantly improve treatment outcomes.\n\nFrequently Asked Questions\nIs Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets safe for long-term use?\n\nYes, when taken under medical supervision, it is generally considered safe for long-term diabetes management.\n\nCan this medicine help reduce HbA1c levels?\n\nYes, this combination is effective in lowering HbA1c and maintaining blood sugar control.\n\nDoes this medicine cause weight gain?\n\nDapagliflozin may support mild weight reduction in some patients.\n\nCan I stop the medicine once sugar levels improve?\n\nDo not stop taking the medicine without consulting your doctor.\n\nIs this medicine suitable for elderly patients?\n\nIt may be prescribed to elderly patients after proper medical evaluation.\n\nConclusion\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg tablets are a highly effective triple-combination therapy for managing type 2 diabetes mellitus. By combining the benefits of dapagliflozin, vildagliptin, and metformin SR, this medicine provides comprehensive blood sugar control, improves insulin sensitivity, and helps reduce diabetes-related complications.", "price": 375.0, "discountamount": 113.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2422, "imageuri": "https://productimages.withfloats.com/actual/6a06f00b91493d06f6e7fcdf.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a06f00b91493d06f6e7fcdf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-15T10:05:57.462Z", "updatedon": "2026-06-05T07:31:14.082Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-vildagliptin-100-metformin-1000/2422", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DAPAVILDA MET 10/100/1000", "category": "DIABETIC RANGE", "tags": [ "dapagliflozin 10 vildagliptin 100 metformin 1000", "dapagliflozin vildagliptin metformin", "dapagliflozin vildagliptin metformin combination", "dapagliflozin vildagliptin metformin 1000", "Dapagliflozin + Vildagliptin + Metformin Tablets", "Buy Dapagliflozin + Vildagliptin + Metformin Tablets Online", "Type 2 Diabetes Treatment Tablets", "Blood Sugar Control Medicine with Dapagliflozin, Vildagliptin & Metformin", "Triple Combination Anti-Diabetic Tablets", "Best Diabetes Control Tablets for Type 2 Diabetes", "Prescription Anti-Diabetic Medicine Tablets", "Dapagliflozin 10 mg Vildagliptin 100 mg Metformin 1000 mg Product Image", "Premium Quality Diabetic Care Tablets", "Combination Diabetes Medicine for Glycemic Control", "Type 2 Diabetes Management Tablets Online", "Advanced Blood Sugar Control Tablets", "Dapagliflozin Vildagliptin Metformin Tablets Supplier in India", "Dapagliflozin Vildagliptin Metformin Tablets Manufacturer in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }